You would need two injections with a 1.0 ml syringe, or reconstitute at higher concentration
New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity
Weight loss triggers hormonal and metabolic changes that push your body to regain weight and make you especially hungry
Social media also plays a major role, as platforms like Instagram and TikTok drive interest in GLP1 treatments through engaging videos and real patient stories
The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough
Protein Protein has long been associated with feeling fuller after meals, and GLP-1 helps explain why
